guest ::
| Home > Publications Database > Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity. > print |
| Home > Publications Database > Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity. > print |
| 001 | 285453 | ||
| 005 | 20260305131037.0 | ||
| 024 | 7 | _ | |a 10.1073/pnas.2516774123 |2 doi |
| 024 | 7 | _ | |a pmid:41770935 |2 pmid |
| 024 | 7 | _ | |a 0027-8424 |2 ISSN |
| 024 | 7 | _ | |a 1091-6490 |2 ISSN |
| 037 | _ | _ | |a DZNE-2026-00235 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 500 |
| 100 | 1 | _ | |a Konstantoulea, Katerina |0 0000-0002-0960-6274 |b 0 |
| 245 | _ | _ | |a Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity. |
| 260 | _ | _ | |a Washington, DC |c 2026 |b National Acad. of Sciences |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1772633891_4244 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The prevailing view frames microglia and macrophages as guardians against amyloid beta (Aβ) accumulation in Alzheimer's disease (AD). Here, we overturn this paradigm by demonstrating that human phagocytic cells, including differentiated THP-1 macrophages and hESC-derived microglia, are not merely passive responders but active producers of extracellular, seeding-competent Aβ42 fibrils, the amyloid species most strongly linked to parenchymal plaque formation and neurodegeneration. These cell-generated aggregates differ structurally and functionally from synthetic fibrils, displaying enhanced seeding and tau cross-seeding activity in biosensor models. Notably, Aβ42 fibril formation in this system requires active cellular processes and is exacerbated by loss of Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a major AD risk gene. Transcriptomic profiling reveals an early inflammatory response resembling microglial states observed in human AD models. Together, these findings support emerging evidence from in vivo studies that macrophages and microglia can influence amyloid seeding and introduce a human-relevant in vitro platform to explore how Aβ aggregation intersects with innate immune function and genetic risk. Our results reinforce the concept that microglia may play a dual role in AD, acting both as responders and inadvertent facilitators of amyloid assembly, with implications for early therapeutic intervention. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Ab42 |2 Other |
| 650 | _ | 7 | |a Alzheimer’s disease |2 Other |
| 650 | _ | 7 | |a TREM2 |2 Other |
| 650 | _ | 7 | |a microglia |2 Other |
| 700 | 1 | _ | |a Ramakers, Meine |0 0000-0002-9417-4196 |b 1 |
| 700 | 1 | _ | |a Borrie, Sarah C |0 0000-0002-6880-772X |b 2 |
| 700 | 1 | _ | |a T'Syen, Dries |b 3 |
| 700 | 1 | _ | |a Moechars, Daan |b 4 |
| 700 | 1 | _ | |a Sliwinska, Malgorzata A |0 0000-0002-5016-4949 |b 5 |
| 700 | 1 | _ | |a Pradhan, Brajabandhu |b 6 |
| 700 | 1 | _ | |a Albertini, Giulia |b 7 |
| 700 | 1 | _ | |a Baligács, Nóra |0 0000-0002-2246-3669 |b 8 |
| 700 | 1 | _ | |a Tsaka, Grigoria |0 0000-0002-8896-4191 |b 9 |
| 700 | 1 | _ | |a Houben, Bert |b 10 |
| 700 | 1 | _ | |a Fiers, Mark |b 11 |
| 700 | 1 | _ | |a Gallardo, Rodrigo |0 0000-0003-1584-3564 |b 12 |
| 700 | 1 | _ | |a Dewilde, Maarten |0 0000-0002-3138-281X |b 13 |
| 700 | 1 | _ | |a Thal, Dietmar Rudolf |0 0000-0002-1036-1075 |b 14 |
| 700 | 1 | _ | |a Willem, Michael |b 15 |
| 700 | 1 | _ | |a Neher, Jonas J |0 P:(DE-2719)2811021 |b 16 |u dzne |
| 700 | 1 | _ | |a De Strooper, Bart |0 0000-0001-5455-5819 |b 17 |
| 700 | 1 | _ | |a Rousseau, Frederic |0 0000-0002-9189-7399 |b 18 |
| 700 | 1 | _ | |a Schymkowitz, Joost |0 0000-0003-2020-0168 |b 19 |
| 773 | _ | _ | |a 10.1073/pnas.2516774123 |g Vol. 123, no. 10, p. e2516774123 |0 PERI:(DE-600)1461794-8 |n 10 |p e2516774123 |t Proceedings of the National Academy of Sciences of the United States of America |v 123 |y 2026 |x 0027-8424 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/285453/files/DZNE-2026-00235.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/285453/files/DZNE-2026-00235%20SUP.pdf |
| 856 | 4 | _ | |x pdfa |u https://pub.dzne.de/record/285453/files/DZNE-2026-00235%20SUP.pdf?subformat=pdfa |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/285453/files/DZNE-2026-00235.pdf?subformat=pdfa |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2811021 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2026 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2024-12-10 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b P NATL ACAD SCI USA : 2022 |d 2024-12-10 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b P NATL ACAD SCI USA : 2022 |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-10 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-10 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2024-12-10 |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2024-12-10 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-10 |
| 920 | 1 | _ | |0 I:(DE-2719)1110011 |k AG Neher (München) |l Neuroimmunology and Neurodegenerative Disease |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1110011 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|